Intellectual Property: Patent

About

Provided by Goodwin

Our IP litigation team is notable for our expertise representing both innovators and generics in Hatch-Waxman litigation and pharmaceutical and biotechnology related IPRs, and for our IP appellate team, which has successfully argued and prevailed in some of the most significant IP-related Federal Circuit and Supreme Court cases in recent years. We have a history of leadership in Hatch-Waxman litigation and Lex Machina’s Hatch-Waxman/ANDA Litigation Report regularly notes that Goodwin is among the top law firms in terms of volume of Hatch-Waxman cases.

We also continue to be the premier source for current biosimilars legal news through our award-winning Big Molecule Watch blog and its companion blog, Big Molecule Watch: China.